Briefing
High-Sensitivity Mutation Analysis of Cell-Free DNA for Disease Monitoring in Endometrial Cancer
MSK high-sensitivity cfDNA sequencing: baseline or postsurgical ctDNA was associated with reduced PFS; in 6 patients with recurrence, ctDNA fraction tracked disease and therapy response, with a lead time in two cases.
- Design: Evidence level 3
- Assay: Not named in the abstract
Clin Cancer ResPubMed 36007103DOI 10.1158/1078-0432.CCR-22-1134